Tissue engineering solutions to replace contractile function during pediatric heart surgery

Tissue Cell. 2020 Dec:67:101452. doi: 10.1016/j.tice.2020.101452. Epub 2020 Oct 23.

Abstract

Pediatric heart surgery remains challenging due to the small size of the pediatric heart, the severity of congenital abnormalities and the unique characteristics of each case. New tools and technologies are needed to tackle this enormous challenge. Tissue engineering strategies are focused on fabricating contractile heart muscle, ventricles, Fontan pumps and whole hearts, and a transplantable tissue equivalent has tremendous implications in pediatric heart surgery to provide functional cardiac tissue. This technology will prove to be a game-changer in the field of pediatric heart surgery and provide a novel toolkit for pediatric heart surgeons. This review will provide insight into the potential applications of tissue engineering technologies to replace lost contractile function in pediatric patients with heart abnormalities.

Keywords: Fontan pumps; HLHS; Pediatric heart surgery; Single ventricle.

Publication types

  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / pharmacology
  • Bioreactors
  • Cardiac Surgical Procedures*
  • Child
  • Humans
  • Models, Animal
  • Myocardial Contraction / physiology*
  • Tissue Engineering / methods*

Substances

  • Biocompatible Materials